<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="5347">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03037333</url>
  </required_header>
  <id_info>
    <org_study_id>PSInCor-EMERG-TV-PAC</org_study_id>
    <nct_id>NCT03037333</nct_id>
  </id_info>
  <brief_title>Analysis in the EMERGEncy Between TransVenous Cardiac PACIng Guided by Fluoroscopy Versus Echocardiogram</brief_title>
  <acronym>EMERG-TV-PAC</acronym>
  <official_title>Prospective Analysis in the EMERGEncy Between TransVenous Cardiac PACIng Guided by Fluoroscopy Versus Echocardiogram</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A lot of questions about use of temporary transvenous pacing still remain obscure and there
      is no effective comparison between use of fluoroscopy versus
      electrocardiogram/echocardiogram in patients with bradicardias. The aim of the study is to
      evaluate how long does it take to start the correct cardiac stimulation with transvenous
      pacing in patients with bradicardias comparing use of fluoroscopy versus
      electrocardiogram/echocardiogram and compare rates of complications between two methods.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Approximately 150 subjects will be recruited over a planned recruitment period of 18 months.
      Patients will be submitted to ecchocardiogram using Philips Envisor, and electrocardiogram
      with Philips Healthcare PageWriter TC30.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>January 2017</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>all cause mortality</measure>
    <time_frame>1 week</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>infection</measure>
    <time_frame>1 week</time_frame>
    <description>Incidence of infection assessed by a clinical diagnosis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>hematoma &gt; 5 cm</measure>
    <time_frame>1 week</time_frame>
    <description>image</description>
  </primary_outcome>
  <primary_outcome>
    <measure>cardiac perforation</measure>
    <time_frame>1 week</time_frame>
    <description>Incidence of cardiac perforation assessed by a clinical diagnosis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>pneumothorax</measure>
    <time_frame>1 week</time_frame>
    <description>Incidence of pneumothorax assessed by a clinical diagnosis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ventricular tachycardia</measure>
    <time_frame>1 week</time_frame>
    <description>Incidence of ventricular tachycardia assessed by an ECG test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>loss of capture</measure>
    <time_frame>1 week</time_frame>
    <description>Incidence of loss of capture assessed by an ECG test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>venous thrombosis</measure>
    <time_frame>1 week</time_frame>
    <description>Incidence of venous thrombosis assessed by an ultrasound</description>
  </primary_outcome>
  <primary_outcome>
    <measure>any complication the delays definitive pacemaker &gt; 48 hours</measure>
    <time_frame>1 week</time_frame>
    <description>clinical diagnosis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to start the correct cardiac stimulation with transvenous pacing</measure>
    <time_frame>1 week</time_frame>
    <description>minutes scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>rates of success</measure>
    <time_frame>1 week</time_frame>
    <description>ECG test</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Bradycardia</condition>
  <arm_group>
    <arm_group_label>fluoroscopy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>ECG/ECHO</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transvenous cardiac pacing guided by fluoroscopy</intervention_name>
    <description>Transvenous cardiac estimulation</description>
    <arm_group_label>fluoroscopy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transvenous cardiac pacing guided by ECG/ECHO</intervention_name>
    <description>Transvenous cardiac estimulation</description>
    <arm_group_label>ECG/ECHO</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult males and females aged &gt; 18 years

          -  symptomatic bradicardia

          -  informed consent signed.

        Exclusion Criteria:

          -  pregnancy

          -  hemodynamic instability (pulmonary congestion / systolic arterial pressure lower than
             90 mmHg)

          -  body mass index greater than 40 kg/ m2

          -  use of oral anticoagulation

          -  acute coronary syndromes

          -  left ventricle ejection fraction &lt; 45%

          -  presence of any kind of cardiac stimulation device
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <link>
    <url>http://journals.sagepub.com/doi/pdf/10.1177/2048872615572598</url>
  </link>
  <link>
    <url>http://onlinelibrary.wiley.com/doi/10.1111/jce.12005/abstract</url>
  </link>
  <link>
    <url>https://cardiovascularultrasound.biomedcentral.com/articles/10.1186/s12947-015-0004-9</url>
  </link>
  <results_reference>
    <citation>Esmaiel A, Hassan J, Blenkhorn F, Mardigyan V. The Use of Ultrasound to Improve Axillary Vein Access and Minimize Complications during Pacemaker Implantation. Pacing Clin Electrophysiol. 2016 May;39(5):478-82. doi: 10.1111/pace.12833. Epub 2016 Mar 23.</citation>
    <PMID>26880272</PMID>
  </results_reference>
  <results_reference>
    <citation>Reusz G, Csomos A. The role of ultrasound guidance for vascular access. Curr Opin Anaesthesiol. 2015 Dec;28(6):710-6. doi: 10.1097/ACO.0000000000000245. Review.</citation>
    <PMID>26539789</PMID>
  </results_reference>
  <results_reference>
    <citation>Bouaziz H, Zetlaoui PJ, Pierre S, Desruennes E, Fritsch N, Jochum D, Lapostolle F, Pirotte T, Villiers S. Guidelines on the use of ultrasound guidance for vascular access. Anaesth Crit Care Pain Med. 2015 Feb;34(1):65-9. doi: 10.1016/j.accpm.2015.01.004. Epub 2015 Mar 5.</citation>
    <PMID>25829319</PMID>
  </results_reference>
  <verification_date>January 2017</verification_date>
  <lastchanged_date>January 27, 2017</lastchanged_date>
  <firstreceived_date>January 18, 2017</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>echocardiogram</keyword>
  <keyword>Electrocardiogram: Electrical Alternans</keyword>
  <keyword>fluoroscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Emergencies</mesh_term>
    <mesh_term>Bradycardia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
